Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Marit

Showing results (71-80 of 107) with videos related to

Pageof 11
Sort By:
Leukemia|December 1, 1995
Response to recombinant interferon alpha in patients with chronic myelogenous leukemia in a single center: results and analysis of predictive factorsM Montastruc, F X Mahon, C Fabères, et al.
British Journal of Haematology|May 1, 1989
Comparison of allogeneic or autologous bone marrow transplantation and chemotherapy in patients with acute myeloid leukaemia in first remission: a prospective controlled trialJ Reiffers, M H Gaspard, D Maraninchi, et al.
Stem Cells (Dayton, Ohio)|August 1, 1995
Autologous stem cell transplantation after first remission induction treatment in multiple myeloma. A report of the French Registry on Autologous Transplantation in Multiple MyelomaJ L Harousseau, M Attal, M Divine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
Follow-up of complete cytogenetic remission in patients with chronic myeloid leukemia after cessation of interferon alfaF X Mahon, X Delbrel, P Cony-Makhoul, et al.
Blood|June 1, 1995
Autologous stem cell transplantation after first remission induction treatment in multiple myeloma: a report of the French Registry on autologous transplantation in multiple myelomaJ L Harousseau, M Attal, M Divine, et al.
Cancer Causes & Control : CCC|September 11, 2008
Cigarette smoking, alcohol drinking, and risk of lymphoid neoplasms: results of a French case-control studyA Monnereau, L Orsi, X Troussard, et al.
European Journal of Haematology|February 19, 2000
Increased liposome-mediated gene transfer into haematopoietic cells grown in adhesion to stromal or fibroblast cell line monolayersG Marit, Y Cao, P Froussard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 2006
Phase II study of gemcitabine-dexamethasone with or without cisplatin in relapsed or refractory mantle cell lymphomaF Morschhauser, S Depil, E Jourdan, et al.
Blood|June 14, 2000
Quality of life-adjusted survival analysis of high-dose therapy with autologous bone marrow transplantation versus sequential chemotherapy for patients with aggressive lymphoma in first complete remission. Groupe d'Etude les Lymphomes de l'Adulte (GELA)N Mounier, C Haioun, B F Cole, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2003
Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large-B-cell lymphoma: influence of rituximabP Feugier, J M Virion, H Tilly, et al.
Pageof 11

Showing results (71-80 of 107) with videos related to

Sort By:
Pageof 11
Leukemia|December 1, 1995
Response to recombinant interferon alpha in patients with chronic myelogenous leukemia in a single center: results and analysis of predictive factorsM Montastruc, F X Mahon, C Fabères, et al.
British Journal of Haematology|May 1, 1989
Comparison of allogeneic or autologous bone marrow transplantation and chemotherapy in patients with acute myeloid leukaemia in first remission: a prospective controlled trialJ Reiffers, M H Gaspard, D Maraninchi, et al.
Stem Cells (Dayton, Ohio)|August 1, 1995
Autologous stem cell transplantation after first remission induction treatment in multiple myeloma. A report of the French Registry on Autologous Transplantation in Multiple MyelomaJ L Harousseau, M Attal, M Divine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
Follow-up of complete cytogenetic remission in patients with chronic myeloid leukemia after cessation of interferon alfaF X Mahon, X Delbrel, P Cony-Makhoul, et al.
Blood|June 1, 1995
Autologous stem cell transplantation after first remission induction treatment in multiple myeloma: a report of the French Registry on autologous transplantation in multiple myelomaJ L Harousseau, M Attal, M Divine, et al.
Cancer Causes & Control : CCC|September 11, 2008
Cigarette smoking, alcohol drinking, and risk of lymphoid neoplasms: results of a French case-control studyA Monnereau, L Orsi, X Troussard, et al.
European Journal of Haematology|February 19, 2000
Increased liposome-mediated gene transfer into haematopoietic cells grown in adhesion to stromal or fibroblast cell line monolayersG Marit, Y Cao, P Froussard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 2006
Phase II study of gemcitabine-dexamethasone with or without cisplatin in relapsed or refractory mantle cell lymphomaF Morschhauser, S Depil, E Jourdan, et al.
Blood|June 14, 2000
Quality of life-adjusted survival analysis of high-dose therapy with autologous bone marrow transplantation versus sequential chemotherapy for patients with aggressive lymphoma in first complete remission. Groupe d'Etude les Lymphomes de l'Adulte (GELA)N Mounier, C Haioun, B F Cole, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2003
Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large-B-cell lymphoma: influence of rituximabP Feugier, J M Virion, H Tilly, et al.
Pageof 11